News
Protein Sciences Corporation News
Web Site:
http://www.proteinsciences.com
- Sanofi Pasteur Inc.
1000 Research Pkwy.,
Meriden, CT 06450
- 7159
Tel: (203) 686-0800
Fax: (203) 686-0268
Protein Sciences Corporation, founded in 1983, is a privately held vaccine company with headquarters in Meriden, Connecticut. PSC's mission is to save lives and improve health.
Related News:
- New England Journal of Medicine Publishes FluBlok � is Better June 26, 2017
- Protein Sciences Gears Up to Combat Pandemic Influenza March 26, 2017
- Protein Sciences Corp. Zika Vaccine Candidate Had Good Safety Results January 11, 2017
- U.S. Biomedical Advanced Research & Development Authority (BARDA) Awards Protein Sciences Multi-Million Dollar Contract for Pandemic Preparedness September 11, 2016
- Protein Sciences Corporation, Sinergium Biotech and Mundo Sano Announce Zika Vaccine Partnership April 20, 2016
- Protein Sciences and Orygen Biotecnologia Announce Agreement to License Flublok� Influenza Vaccine for Brazil April 11, 2016
- Protein Sciences and UNIGEN Reach Agreement to Source Flublok� Influenza Vaccine from Japan February 14, 2016
- Protein Sciences & CT Food Bank Partner to Offer Flublok� Influenza Vaccine to Those In Need November 30, 2015
- Flublok� Influenza Vaccine Approved in Mexico November 17, 2015
- Protein Sciences Corporation Receives Bipartisan Support for Flublok� November 4, 2015